Maze Therapeutics, Inc. (MAZE) bonds
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$32.87−1.03 (-3.04%)
Close on Nov 17, 2026Market cap $1.83BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$38.96M
$0 due within a year
Net debt
-$163.68M
After $202.64M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Maze Therapeutics's 10-Q for the period ended Feb 4, 2026
| Issue | Amount issued |
|---|---|
| Additional Tranches | $160.00M |
| Final Tranche | $50.00M |
| Tranche 1A | $40.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?